If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Keep me logged in Forgot your password?

Please wait...

Please wait...

News in Brief

Spread of Bladder Cancer To Lungs Tied to a Protein

April 30, 2012

Versican—a protein involved in cancer cell migration—is a driver of lung metastasis in bladder cancer.
 

RCC Subtype Is Associated With Low Recurrence Rate

April 29, 2012

Patients with papillary renal cell carcinoma (pRCC) have a low risk of tumor recurrence and cancer-related death after surgery.
 

Renal Function Can Improve Despite CKD, Study Finds

April 29, 2012

Data from 12 years of follow-up provides strong evidence that renal function can improve in some patients with hypertensive CKD.
 

Too Much Fat May Harm Sperm Quality

April 28, 2012

Higher total fat intake was negatively related to total sperm count and concentration in an analysis of data from 99 men.
 

Circumcision May Reduce PCa Risk

April 28, 2012

Recent population-based study findings indicate that circumcision before first sexual intercourse is associated with a reduction in the relative risk of prostate cancer (PCa).
 

Physician Reminders Fail to Increase ACE/ARB Use

April 01, 2012

Treatment reminders fail to increase the rate at which primary care physicians (PCPs) prescribe ACE inhibitors or angiotensin receptor blockers (ARBs) for elderly patients with chronic kidney disease (CKD).
 

HD Is An Independent Risk Factor for Atherosclerosis

April 01, 2012

Hemodialysis (HD) is an independent risk factor for atherosclerosis in patents who have chronic renal failure (CRF).
 

Kidney Donation Does Not Increase CV Risk

April 01, 2012

Kidney donors are at no greater risk for cardiovascular (CV) events or death than non-donors.
 

PCa Risk Higher In Men with Heart Disease

April 01, 2012

Coronary artery disease (CAD) was associated with a 35% increased risk of a prostate cancer (PCa) diagnosis.
 

Should bone scans be ordered for almost every patient newly diagnosed with prostate cancer?

March 30, 2012

Most men with incidental prostate cancer do not require staging imaging, according to guidelines.
 

FDA Clears Once-Monthly Drug for Anemia in Dialysis Patients

March 27, 2012

The FDA has approved peginesatide (Omontys) for the treatment of anemia in adult dialysis patients.
 

CP/CPPS May Increase Risk of Colorectal Cancer

March 13, 2012

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) may put men at increased risk for colorectal cancer, a study found. The association was most prominent among men younger than 60 years.
 

Device Cleared for Female Urinary Incontinence

March 02, 2012

The FDA has cleared InTone, a medical device for treating female urinary incontinence.
 

Adverse RP Effects Not Lessened with Robotics

March 01, 2012

Patients undergoing prostate cancer surgery will face similar risks for incontinence and sexual problems whether they undergo robotic-assisted laparoscopic radical prostectomy (RP) or open RP.
 

Renal Decline Linked to TNF Receptors

March 01, 2012

High levels of tumor necrosis factor (TNF) receptors 1 and 2 are associated with an increased risk of kidney disease in patients with type 1 diabetes.
 

Vytorin Label Will Include Kidney Data

February 29, 2012

The FDA has approved new labeling for the cardiovascular agent Vytorin (ezetimibe/simvastatin) that will include data from the Study of Heart and Renal Protection (SHARP).
 

Study: Form of Bladder Cancer Increased by 56%

February 22, 2012

Although a detailed trend analysis of 127,614 U.S. cases of first primary bladder cancer demonstrated a 9% overall drop in disease occurrence between 1973 and 2007, papillary transitional cell carcinoma (PTCC)—one of two main subtypes—increased by 56% over that period.
 

Biomarkers Identify Acute Kidney Injury in Emergency Patients

February 20, 2012

In an international study of 1,635 emergency-department patients, urinary neutrophil gelatinase-associated lipocalin (uNGAL) was the most useful of five urinary biomarkers in predicting the severity and duration of acute kidney injury (AKI) at the time of hospital admission, with 81% specificity and 68% sensitivity at a cutoff of 104 ng/mL.
 

Dietary Calcium May Decrease Prostate Cancer Risk

February 17, 2012

Dietary calcium is associated with lower risk for prostate cancer (PCa), particularly among black men, and with a lower risk for high-grade prostate cancer among all men, according to a study involving 108 U.S. veterans with biopsy-positive prostate cancer, 161 biopsy-negative controls, and 237 healthy controls.
 

Are you more likely today to recommend active surveillance for selected patients with low-risk prostate cancer than you were five years ago?

February 13, 2012

Evidence is accumulating that active surveillance is an appropriate way to manage low-risk prostate cancer in selected men, with curative treatment delayed until it is warranted by indicators of disease progression.
 

Newsletters

Sign up to start receiving free e-newsletters from Renal & Urology News, including:

  • Latest News
  • Latest CME
  • Ongoing Clinical Trials
  • Conference Highlights
  • Expert Q&A

Your Practice


The move from ICD-9-CM to ICD-10 is enough to strike fear into the hearts of physicians and staff alike. Making the leap from 14,000 codes to almost 69,000, topped with the huge cost to make that change, is understandably daunting.

Read more on
Coping with ICD-10


Have any practice management topics that you'd like us to cover?
Let us know.

Commentary


Dr. Uzzo

The merits of PSA screening have been widely debated due largely to its low specificity for prostate cancer (PCa), especially for high-grade disease.

Current Poll


Has a radiologist ever challenged one of your orders for an imaging procedure?

Click here to take the poll

Clinical Quiz


Small Renal Masses and Drug-Eluting Stents — How to Best Balance the Risks?



A 55-year-old male with significant history of coronary artery disease is found to have an intraparenchymal 2 cm left-enhancing small renal mass. Answer the quiz correctly and you'll have a chance to win an American Express gift card.

Expert Q&A

Optimal Sequencing of the New Prostate Cancer Drugs: An Interview with E. David Crawford, MD

E. David Crawford, MD


Several new drugs have become available for treating advanced prostate cancer in the past year and a half. Dr. Crawford talks to Renal & Urology News about the possible ways in which these drugs might be used.
 Subscribe to the RSS for this page  [view all our RSS feeds here]

 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions